Results from a new study published in JAMA find that among patients with major depressive disorder (MDD), a single 25-mg dose of psilocybin led to a steady reduction in depressive symptoms and helped improve psychosocial functioning. The goal of the research was to examine the safety and efficacy of using psilocybin in patients with MDD.

A new report from CDC finds that in recent years, the number of people who overdosed and died from counterfeit prescription drugs has more than doubled. From mid-2019 to the end of 2021, overdose deaths involving counterfeit drugs increased from 2% to 4.7%.

According to a new recommendation statement published in JAMA, the U.S. Preventive Services Task Force (USPSTF) recommends PrEP for those at high risk of contracting HIV to comprise newer antiretroviral drugs, including a long-acting option.